Hangzhou, China, Sept. 22, 2025 — WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical” or the “Company”), a provider of medical devices in China, announced today that its subsidiary, Work (Hangzhou) Medical Treatment Equipment Co., Ltd. (“Work Hangzhou”), along with its Chinese subsidiaries, has finalized a strategic cooperation agreement (the “Agreement”) with the Wuxi Branch of Ruijin Hospital-Shanghai Jiao Tong University School of Medicine (“Xin Rui Hospital”). This partnership aims to jointly develop medical products leveraging artificial intelligence (the “AI”). This collaboration is a significant step in advancing WORK Medical’s AI strategy, with the objective of accelerating the creation of a next-generation, AI-powered smart clinical ecosystem.
Under the terms of the Agreement, Work Hangzhou commits to supporting Xin Rui Hospital in enhancing its hospital informatization and the implementation of AI-driven medical products. Both parties intend to integrate AI technology with Xin Rui Hospital’s diverse medical resources, including textual, imaging, and laboratory data, to establish a digital knowledge base for intelligent healthcare. Utilizing Xin Rui Hospital’s clinical diagnostic, treatment, and expert resources, Work Hangzhou also plans to improve its multimodal universal medical AI solution, expanding its capabilities from single-image data to complex multimodal data. This collaboration is anticipated to propel the development, training, and clinical deployment of AI models across various healthcare scenarios, as both entities strive to build a comprehensive framework encompassing data governance, model training, and the practical translation of research into clinical use.
Xin Rui Hospital, located in Wuxi, Jiangsu Province, China, is a Grade 3-Class B tertiary hospital affiliated with Ruijin Hospital–Shanghai Jiao Tong University School of Medicine, which itself is one of China’s leading Grade 3-Class A tertiary hospitals and a National Clinical Research Center as designated by the National Health Commission.
Mr. Wu Shuang, chief executive officer and chairman of WORK Medical, commented: “We are thrilled to collaborate with Xin Rui Hospital. By combining our specialized knowledge with Xin Rui Hospital’s clinical data and real-world environment, we aspire to create a model for hospital digitalization and intelligent healthcare applications. We anticipate that this partnership will expedite the AI transformation of domestic hospitals, broaden the adoption of our technological solutions, foster the growth of AI-driven healthcare, and generate new prospects and long-term value for WORK Medical.”
About WORK Medical Technology Group LTD
WORK Medical Technology Group LTD, operating through its subsidiary, Work (Hangzhou) Medical Treatment Equipment Co., Ltd. and its other subsidiaries in China, functions as a supplier of medical devices. It develops and manufactures Class I and II medical devices and distributes Class I and II disposable medical devices via its operating subsidiaries within China. The Company offers a varied product portfolio comprising 21 distinct products, including customized and multifunctional masks, alongside other medical consumables. All of these products have been sold across 34 provincial-level administrative regions in China, with 15 of them also distributed in over 30 countries globally. The Company has secured numerous quality-related manufacturing designations and has registered 17 products with the U.S. Food and Drug Administration, enabling their entry into the U.S. market. For more details, please visit the Company’s website: .
Forward-Looking Statements
This press release contains forward-looking statements, which include those made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements are often identifiable by terms such as “aims,” “anticipates,” “believes,” “could,” “estimates,” “expects,” “forecasts,” “goal,” “intends,” “may,” “plans,” “possible,” “potential,” “seeks,” “will,” and similar expressions intended to denote forward-looking statements. Any statement in this press release that is not a historical fact should be considered a forward-looking statement. Such forward-looking statements in this press release are based on the Company’s current expectations, estimates, and projections solely as of the date of this release and are subject to various risks and uncertainties that could cause actual results to differ significantly and negatively from those presented or implied by these statements. Although the Company believes that the expectations conveyed in these forward-looking statements are reasonable, it cannot guarantee their accuracy. The Company advises investors that actual results may vary materially from the anticipated outcomes and encourages them to review other factors that could influence its future results, as detailed in the Company’s annual report on Form 20-F and other documents filed with the U.S. Securities and Exchange Commission. The Company explicitly disclaims any responsibility to update any forward-looking statements, except where required by law.
For more information, please contact:
WORK Medical Technology Group LTD
Investor Relations Department
Email:
Ascent Investor Relations LLC
Tina Xiao
Phone: +1-646-932-7242
Email:
